Buformin

Subscribe to Selected New Research on Buformin

59 relevant articles (1 outcomes, 2 trials/studies) found for this Bio-Agent

Description: An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.

Also Known As:

1-Butylbiguanide; Adebit; Andromaco Brand of Buformin; Gliporal; Grossmann Brand of Buformin Hydrochloride; Silubin; Silubin Retard; 1 Butylbiguanide; Buformin Andromaco Brand; Retard, Silubin; Butylbiguanide; Imidodicarbonimidic diamide, N-butyl-

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 40

Experts

1.	Miyao, Mariko: 1 article (03/2005)
2.	Mizuno, Yuzo: 1 article (03/2005)
3.	Matsuura, Takahiko: 1 article (03/2005)
4.	Martínez Laso, A: 1 article (02/2005)
5.	Matsuyama, T: 1 article (11/2004)
6.	Ohara, S: 1 article (11/2004)
7.	Komatsu, R: 1 article (11/2004)
8.	Krishnamurthy, Mahesh: 1 article (10/2004)
9.	Sahouria, Julieanna Jad: 1 article (10/2004)
10.	Desai, Ravi: 1 article (10/2004)

Related Diseases

1.	Hypoglycemia (Reactive Hypoglycemia) 11/01/1975 - "Treatment of reactive hypoglycemia with buformin." 01/01/1969 - "Hypoglycemia induced by N1-(n-butyl)-biguanide (Buformin) in animal experiments]" 11/01/1975 - "Buformin treatment resulted in significant increase of blood glucose values between 180 and 360 min after oral glucose challenge and in considerable improvement of hypoglycemia in nine obese patients with idiopathic reactive hypoglycemia and in the patient with chemical diabetes" 11/01/1975 - "The therapeutic effect of short-term buformin (l-butylbiguanide) treatment was investigated in 12 patients with reactive hypoglycemia" Order ALL the reference details at left...
2.	Neoplasms (Cancer) 01/01/2003 - "The total tumor incidence decreased by 49.5% in buformin-treated rats" 07/01/1980 - "Administration of the antidiabetic drug buformin decreased 3.5-fold the malignant neurogenic tumor incidence in rats transplacentally treated with NMU." 01/01/1980 - "Postnatal administration of the antidiabetic drug buformin decreased the malignant neurogenic tumor incidence 3.5 times (to rats transplacentally treated with NMU)." 01/01/1980 - "Chronic treatment of female rats with buformin (k mg/day per rat) is shown to decrease the body weight, to increase the average life span by 9% and to reduce the incidence of spontaneous tumors" 01/01/1980 - "Effect of buformin and diphenylhydantoin on the life span, estrous function and spontaneous tumor incidence in rats]" Order ALL the reference details at left...
3.	Ketosis 02/01/1967 - "Studies on the effect of Nl,n-butylbiguanide on the blood ketone bodies in eviscerated rabbits with experimental ketosis]" Order ALL the reference details at left...
4.	Lactic Acidosis 03/01/2005 - "A case of lactic acidosis caused by buformin in an oldest elderly diabetic patient]" 02/01/2005 - "A new case of lactic acidosis caused by buformin]" 10/01/2004 - "Buformin-induced lactic acidosis--a symptom of modern healthcare malady." 12/01/1996 - "Lactic acidosis and buformin]" 06/01/1989 - "Lactic acidosis in diabetic patients associated with buformin]" Order ALL the reference details at left...
5.	Diabetes Mellitus 01/01/1978 - "Seven patients suffering from maturity on-set diabetes mellitus were given orally 100 mg of 14C-labelled butylbiguanide, specific activity 1.40 or 1.23 muCi/mg, resp" 06/01/1970 - "Effect of the Hungarian sugar-reducing preparation adebit in patients with diabetes mellitus]" 01/05/1970 - "Therapy of diabetes mellitus with Silubin-retard]" 09/01/1968 - "Our experiences in treatment of diabetes mellitus with silubin R]" 06/01/1966 - "The treatment of diabetes mellitus with a retard form of butylbiguanide." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Blood Glucose (Blood Sugar)
2.	Glucose (Dextrose)
3.	Phenformin (Fenformin)
4.	Biguanides
5.	Ketone Bodies
6.	Metformin (Glucophage)
7.	Insulin (Novolin)
8.	Tolbutamide (Orinase)
9.	Buformin
10.	Carbutamide (Glucidoral)

Best Treatments:
Research Summary Report
on Hypoglycemia

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 377 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>